Lu AF82422

· H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lu AF82422, covering 2024-11-12 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lu AF82422 in Participants With Multiple System Atrophy [Phase 2]